Jane Osbourn Founder of Alchemab Therapeutics Backed bySV Health InvestorsHouman AshrafianNikola Trbovic SourcesAlchemab Therapeutics initiates Phase 1 clinical trial of ATLX-1282 and announces Series A financing — 2025-09 Browse all founders · Browse investors
